Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
GUANYLATE CYCLASE RECEPTOR AGONISTS FOR THE TREATMENT OF TISSUE INFLAMMATION AND CARCINOGENESIS
No-Receipt date
2013-03696 - 27/11/2013
No-Filing date
20130402527 - 27/11/2013
No-Granting date
3070191.B2 - 29/11/2013
No-EPO application date
02721604.3 - 28/03/2002
No-EPO granting date
1379224 - 02/10/2013
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
11/2013 - 02/01/2014
Expiration date
29/03/2022
Kind of title
Amended European Patent Validation
Legal status
NOT VALID
Priorities
US279438 P29/03/2001/US
US279437 P29/03/2001/US
US300850 P27/06/2001/US
US303806 P10/07/2001/US
US307358 P25/07/2001/US
US348646 P17/01/2002/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 38/04
A61K 38/12
A61P 29/00
A61P 35/00
C07K 7/00
C07K 7/64
Related Documents
Related Titles
Type
Master title
Related title
[ADD]
20090402520
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
506780
SYNERGY PHARMACEUTICALS, INC.
SUITE 450 2 EXECUTIVE DRIVE
SOMERSET, NJ 08873
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
1214539
SHAILUBHAI, KUNWAR
1214540
NIKIFOROVICH, GREGORY
1214541
JACOB, GARY, S.
Representatives
Code
Firstname
Surname
Address
Town
Zip
1349
ELENI
PAPAKONSTANTINOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
4007
ELENI
PAPAKONSTANTINOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
GREECE
Owners History
Title Instruments
Date
Operation
Descreption
4/7/2022 12:00:00 AM
Λήξη Προστασίας Τίτλων (79600)
79600
Payments history
20 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).